Ofichem acquires Avivia B.V. to expand formulation development capabilities
Nijmegen, Netherlands, July 1st, 2025: Ofichem Group has signed a definitive agreement to acquire Avivia B.V., a company specialized in formulation development based in Nijmegen, the Netherlands. The acquisition marks a significant step in Ofichem’s strategy to become a fully integrated provider of development solutions across drug substance and drug product, with a focus on […]